NOT SYMPATHY:Ok if not a sympathy play from Sava (what I think this was/is) then why what happened today and yesterday anyone?
FUNDAMENTAL REVALUATION
We've know for a long time that AVXL was ludicrously undervalued and should be at least SAVA's value, if not 50-100% more given the stage of its science.
That science-based analyst report said $45 by year end.
Instead even now it is just half of SAVA's market cap. Fair value for AVXL is $1.5-2 billion or roughly $20-30 a share.